1-deoxynojirimycin has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Liu, J; Tang, J; Wu, F | 1 |
| Martínez-Duncker, I; Mora Montes, HM; Pérez-García, LA | 1 |
| Den Otter, W; Dullens, HF; Vliegenthart, JF; Voshol, H | 1 |
| Baldwin, SA; Bramwell, ME; Davies, A | 1 |
1 review(s) available for 1-deoxynojirimycin and Neoplasms
| Article | Year |
|---|---|
The Endoplasmic Reticulum Alpha-Glycosidases as Potential Targets for Virus Control.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Antineoplastic Agents; Antiviral Agents; Endoplasmic Reticulum; Eukaryotic Cells; Glycoside Hydrolase Inhibitors; Glycosylation; Host-Pathogen Interactions; Humans; Indolizines; Mannosidases; Neoplasms; Protein Processing, Post-Translational; Virus Diseases; Viruses | 2017 |
3 other study(ies) available for 1-deoxynojirimycin and Neoplasms
| Article | Year |
|---|---|
Study on the synthesis and biological activities of α-substituted arylacetates derivatives.
Topics: Acetates; alpha-Glucosidases; Animals; Antineoplastic Agents; Cell Line, Tumor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Neoplasms; Rats; Solanaceous Alkaloids; Structure-Activity Relationship | 2016 |
Cell surface glycoconjugates as possible target structures for human natural killer cells: evidence against the involvement of glycolipids and N-linked carbohydrate chains.
Topics: 1-Deoxynojirimycin; Carbohydrate Conformation; Carbohydrate Metabolism; Carbohydrates; Cell Membrane; Flow Cytometry; Glycoconjugates; Glycolipids; Glycosylation; Humans; Killer Cells, Natural; Lectins; Leukemia, Erythroblastic, Acute; Membrane Proteins; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acids; Trypsin; Tumor Cells, Cultured | 1993 |
Heterogeneity of the glucose transporter in malignant and suppressed hybrid cells.
Topics: 1-Deoxynojirimycin; Animals; Brain; Cell Line; Erythrocytes; Glucosamine; Glycosylation; Humans; Hybrid Cells; Immune Sera; Immunoblotting; Mannosidases; Mice; Monosaccharide Transport Proteins; Neoplasms; Neoplasms, Experimental; Proteins; Rats; Tumor Cells, Cultured; Tunicamycin | 1990 |